Gatti A, Robinson P J
Department of Experimental Oncology, European Institute of Oncology, Milan, Italy.
Eur J Biochem. 1997 Oct 1;249(1):92-7. doi: 10.1111/j.1432-1033.1997.t01-1-00092.x.
A prolonged cell exposure of all examined cell types to tumour-promoting phorbol esters leads to a substantial inactivation and degradation of protein kinase C (PKC), a phenomenon known as down-regulation. With a combination of one- and two-dimensional immunoblot analyses we have previously shown the existence in PC12 cells of distinct PKC-alpha forms that differentially respond to cell treatment with phorbol ester [Gatti, A. & Robinson, P. J. (1996) J. Biol. Chem. 271, 31 718-31722]. Using the same experimental model, in the present study we investigated a possible relationship between PKC-alpha phosphorylation and its down-regulation. The exposure of PC12 cells to okadaic acid, a potent inhibitor of biologically relevant protein phosphatases, was found to partially protect PKC-alpha against phorbol-ester-mediated down-regulation. Further, a similar protective effect of okadaic acid was observed for PKC-delta and PKC-epsilon, which are also expressed in PC12 cells. These results indicate that the tumour-promoting activity of okadaic acid itself may be due to a sustained phosphorylation of PKC.
将所有检测的细胞类型长时间暴露于促肿瘤佛波酯会导致蛋白激酶C(PKC)大量失活和降解,这一现象被称为下调。通过一维与二维免疫印迹分析相结合,我们之前已证明PC12细胞中存在不同的PKC-α形式,它们对佛波酯处理细胞的反应存在差异[加蒂,A.和罗宾逊,P.J.(1996年)《生物化学杂志》271卷,31718 - 31722页]。利用相同的实验模型,在本研究中我们探究了PKC-α磷酸化与其下调之间的可能关系。发现将PC12细胞暴露于冈田酸(一种生物相关蛋白磷酸酶的强效抑制剂)可部分保护PKC-α免受佛波酯介导的下调作用。此外,对于同样在PC12细胞中表达的PKC-δ和PKC-ε,也观察到了冈田酸类似的保护作用。这些结果表明,冈田酸本身的促肿瘤活性可能归因于PKC的持续磷酸化。